University of Texas researchers identify antibody SC27 capable of neutralizing all known SARS-CoV-2 variants and related coronaviruses.

Researchers at the University of Texas at Austin have identified an antibody, SC27, capable of neutralizing all known SARS-CoV-2 variants and related coronaviruses. Isolated from a single patient, SC27 shows promise for future COVID-19 treatments. The team has filed a patent and is exploring a universal vaccine to enhance immune response against rapidly mutating viruses. This discovery is particularly relevant as COVID-19 cases rise in the U.S.

September 03, 2024
20 Articles

Further Reading